Practical consequences of HBV DNA screening implementation in blood donors;Praktyczne konsekwencje wprowadzenia badań DNA HBV u dawców krwi

Acta Haematologica Polonica

Volumn 40, Issue 1, 2009, Pages 45-54

  Brojer, E W A ^b   Grabarczyk, Piotr ^c   Liszewski, Grzegorz ^c   Mikulska, Maria ^c   Kopacz, Aneta ^c   ŁEtowska, Magdalena ^a  

^a Instytut Hematologii i Transfuzjologii Kierownik

^b INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^c NONE

Author keywords

Blood donors; DNA HBV; Hbsag; Occult hbv

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; VIRUS DNA;

BLOOD DONOR; DNA SCREENING; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; POLAND; REVIEW; SEQUENCE ANALYSIS; VIREMIA;

EID: 64549118325     PISSN: 00015814     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Coste J, Reesink HW, Engelfriet P i wsp. International Forum. Implementation of donors screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang 2005; 88: 289-303.
2. Brojer E. Implementation of donor sreening for infectious agents transmitted by blood by nucleic acid technology in Poland.Vox Sang, 2005; 89: 267-268.
3. Brojer E, łetowska M, Gronowska A. Nucleic Acid Testing for virus screening in Polish blood donors. Transf Med 2004; 14: 78-79.
4. Stramer SL, Glynn SA, Kleinman SH, i wsp. National Heart, Lung and Blood Institute Nucleic Acid Test Study Group: Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med. 2004; 351: 760-768.
5. Roth K, Weber W i wsp. NAT for HBV and anti-HBc testing increase blood safety. Transfusion 2002; 42 (7): 869-875.
6. Murokawa, H, Yoshikawa, A, Ohnuma H i wsp. Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing. Vox Sang 2005; 88: 10-16.
7. Magdzik W. Wirusowe zapalenie w?troby typu B w Polsce do 2002 roku. PZH. Warszawa 2003.
8. Seyfried H, Grabarczyk P, Mikulska M. i wsp. Analiza czȩ stości wykrywania antygenu HBs u polskich dawców krwi w latach 1995-2007. (w przygotowaniu do druku).
9. Stramer S.L. US NAT yield: where are we after 2 years ? Transfusion Clinique et Biol 2003; 10: 10-18.
10. Alain JP. Occult hepatitis B infection: implications in transfusion. Vox Sang 2004; 86: 83-91.
11. Biswas R, Tabor E, Hsia CC, i wsp. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 2003; 43: 788-798.
12. Yoshikawa A, Gotanda Y, Itabashi M i wsp. HBV NAT positive blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of DNA HBV. Vox Sang 2005; 88: 77-86.
13. Brojer E, Łȩtowska M, Medyńska J. i wsp. Validation of Procleix Ultrio assay in Poland. Vox Sang 2004, 87 (suppl 3): 62.
14. Chudy M, Amberg I, Hanker-Dusel C. i wsp. Procleix Ultrio Assay performance trial. Vox Sang 2004; 87 (suppl 3), 59.
15. Koppelman M, Sjerps M, Reesink H i wsp. Evaluation of Cobas AmpliPrep-AmpliScreen assay for DNA HBV screening. Vox Sang 2004; 87 (suppl 3): 59.
16. Iwamoto M, Jernigan DB, Kao J. i wsp. A molecular analysisis of preS/susrface and pre-core.core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection. J Med Virol 2002; 68: 216-20.
17. Yamamoto K, Horkita M, Tsuda F. i wsp. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 1994; 68: 2671-6.
18. Kleinman SH, Kuhmns MC, Todd DS i wsp. Frequency of DNA HBV detection in US blood donors testing positive for anti-HBc: implications for transfusion transmission and donor screening. Transfusion 2003;43:696-704.
19. Mosley JW, Stevens CE, Aach RD i wsp. Donor screening for antibody to hepatitids B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 1995; 35: 5-12.
20. Dreier J, Kroger M, Diekmann J. i wsp. Low-level viraemia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donor. Transfus Med 2004; 14: 97-103.